Clinical trials
3 active studies led by Energenx Medical LTD., of 5 in all
Source: ClinicalTrials.gov, Studies with Energenx Medical LTD. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 3Markets in public records
- 0Regions & countries
- 3Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Energenx Medical LTD. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Energenx Medical LTD.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Energenx Medical LTD. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Energenx Medical LTD. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Energenx Medical LTD.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Energenx Medical LTD. is in.
From our blog
Stories on the topics Energenx Medical LTD. works in.
Omega-3: Heart, Brain and the Evidence Debate
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Bioinformatics: Making Sense of Health Data
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read